CM4620 is a CRAC channel inhibitor to treat acute pancreatitis.

GSK-7975A is a potent and orally available CRAC channel inhibitor.

YM-58483 is a selective and potent blocker of store-operated Ca2+ entry (SOCE), which can regulate the activation of non-excitable cells such as lymphocytes.

NDMC101 is a potent osteoclastogenesis inhibitor and inhibits osteoclast differentiation via down-regulation of NFATc1-modulated gene express. NDMC101 is similar to the DPP4 substrate and is a significant inhibitor of early T-cell activation via DPP4 inhibition. NDMC101can be used for study of bone disorders, such as rheumatoid arthritis, and synovial inflammation et al .

Tanshinone IIA sulfonate sodium is a water-soluble derivative of tanshinone IIA, which acts as an inhibitor of store-operated Ca2+entry (SOCE), and is used to treat cardiovascular disorders.

MRS 1845 is a potent SOCE inhibitor with can block capacitative Ca2+ entry with IC50 value of 1.7μM in HL-60 cells.

GSK5498A is a selective small molecule blocker of CRAC channel(IC50=1 uM) and inhibit mediator release from mast cells, and pro-inflammatory cytokine release from T-cells in a variety of species.